RxDoctor Payments Data

Richard Cole, MD

Family Medicine · Tullahoma, TNNPI 1578558441

Payments from drug & device makers

$645in general payments, 2019–2025

Across 37 payments — averaging $17.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$190
  • AbbVie$149
  • Novo Nordisk$55
  • Abbott$51
  • GSK$32
  • Bayer$30
  • plus $137 from 9 others

What the payments were for

  • Food & beverage$645100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$645 in reported general payments places this provider in the 50th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$334,879
Medicare patients
514
Services billed
7,006

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban80$75,487
XareltoRivaroxaban120$63,768
OzempicSemaglutide58$58,522
MounjaroTirzepatide53$51,767
JardianceEmpagliflozin113$49,230
Trelegy ElliptaFluticasone/Umeclidin/Vilanter51$44,577
FarxigaDapagliflozin Propanediol48$42,979
Breo ElliptaFluticasone/Vilanterol21$12,457
Tresiba Flextouch U-200Insulin Degludec12$8,120
Atorvastatin Calcium572$7,762
JanuviaSitagliptin Phosphate14$7,640
Repatha SureclickEvolocumab11$5,769
Rosuvastatin Calcium268$4,600
Potassium Chloride150$4,325
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate14$4,266

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$15$63,768120 claims
Novo NordiskOzempic$55$58,52258 claims
GSKTrelegy Ellipta, Breo Ellipta$32$57,03472 claims
Lilly USA, LLCMounjaro$16$51,76753 claims
Boehringer IngelheimJardiance$15$49,230113 claims
AstraZenecaFarxiga$190$42,97948 claims
MerckJanuvia$14$7,64014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Tullahoma

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →